206 related articles for article (PubMed ID: 32065219)
21. MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.
Feng A; Yuan X; Li X
Oncol Rep; 2017 Nov; 38(5):2752-2760. PubMed ID: 29048674
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.
Liu YP; Sun XH; Cao XL; Jiang WW; Wang XX; Zhang YF; Wang JL
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1759-1767. PubMed ID: 28485805
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer.
Lee JW; Guan W; Han S; Hong DK; Kim LS; Kim H
Cancer Sci; 2018 May; 109(5):1404-1413. PubMed ID: 29575368
[TBL] [Abstract][Full Text] [Related]
24. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting
Li J; Li T; Lu Y; Shen G; Guo H; Wu J; Lei C; Du F; Zhou F; Zhao X; Nie Y; Fan D
FASEB J; 2017 Sep; 31(9):3774-3786. PubMed ID: 28512191
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
26. MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.
Song J; Liu Y; Wang T; Li B; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110246. PubMed ID: 32447210
[TBL] [Abstract][Full Text] [Related]
27. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
Zhang M; Wang S; Yi A; Qiao Y
Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4.
Yu T; Wang LN; Li W; Zuo QF; Li MM; Zou QM; Xiao B
Cancer Sci; 2018 May; 109(5):1393-1403. PubMed ID: 29569792
[TBL] [Abstract][Full Text] [Related]
30. MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.
Xiang XJ; Deng J; Liu YW; Wan LY; Feng M; Chen J; Xiong JP
Cell Physiol Biochem; 2015; 36(4):1382-94. PubMed ID: 26159618
[TBL] [Abstract][Full Text] [Related]
31. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
32. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
Chen Z; Xu P; Wang X; Li Y; Yang J; Xia Y; Wang S; Liu H; Xu Z; Li Z
Cancer Lett; 2023 Jul; 565():216235. PubMed ID: 37209945
[TBL] [Abstract][Full Text] [Related]
33. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD
Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723
[TBL] [Abstract][Full Text] [Related]
34. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
Zhao C; Li Y; Chen G; Wang F; Shen Z; Zhou R
Oncol Rep; 2017 Jul; 38(1):352-358. PubMed ID: 28560431
[TBL] [Abstract][Full Text] [Related]
36. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
Cao HY; Xiao CH; Lu HJ; Yu HZ; Hong H; Guo CY; Yuan JF
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6478-6485. PubMed ID: 31378887
[TBL] [Abstract][Full Text] [Related]
37. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
[TBL] [Abstract][Full Text] [Related]
39. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/KAT6B axis.
Cheng W; Luan P; Jin X
Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
[TBL] [Abstract][Full Text] [Related]
40. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
